Latest Japan News

AnteoTech has secured independent validation for its Ultranode™ 95 silicon anode in commercial drone battery cells, launched a new battery additive, and strengthened its cash position with a A$10 million capital raise.

NH3 Clean Energy (ASX:NH3) has updated investors on its WAH2 Project, aiming for commercial operations by 2030 to produce low-emissions ammonia for Asia-Pacific markets. The presentation highlights strategic advantages, partnerships, and a phased development plan amid ongoing contract and financing negotiations.

Alcoa Corporation delivered a record quarterly revenue of $4 billion in Q2 2026, boosted by strong aluminium prices and operational restarts, while advancing a major acquisition of South32’s upstream assets.

ECP Emerging Growth Limited rebounded in the June quarter with a 6.1% portfolio gain and an 8.4% lift in net tangible asset value, driven by strong performances in AI-related holdings and consumer growth stocks.

Talga Group has signed a non-binding Letter of Intent with Japan’s Dainen Materials to supply its Talnode®-C battery anode from Sweden, aiming for a binding agreement by year-end. This deepens a five-year partnership and positions Talga in Japan’s demanding battery market.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

EQ Resources reported FY26 tungsten production of 1,189 tonnes WO3 and is advancing major expansion projects at its Mt Carbine and Barruecopardo mines to more than triple output amid tightening global supply.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.

Victory Metals advances its North Stanmore project by sending heavy rare earth concentrate to potential offtake partners and expanding its ore reserve through updated geological classification.

Element 25 is pushing ahead with its Butcherbird manganese mine expansion in Western Australia and developing a first-of-its-kind US high-purity manganese sulphate facility, backed by major OEM partnerships and a US$166 million DOE grant.

Dimerix will provide continued access to its investigational drug DMX-200 for eligible patients with focal segmental glomerular sclerosis after completing the pivotal ACTION3 Phase 3 trial, supporting ongoing treatment ahead of regulatory approval.

Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.